The Fritz-Lampert-Award of the TRANSAID-foundation for cancer-suffering children of the year 2016 has been awarded to Alexander Schramm (C1), head of the pediatric-oncologic research lab at the University Clinic Essen. The german-russian research award recognises excellent researchers and their work in the field of pediatric hematology and oncology for fundamental and clinical research. The award has been handed over at the semi-annual meeting of the Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) in Frankfurt at the 8th of November.
Recognised was his work in the publication Mutational dynamics between primary and relapse neuroblastomas, published together with national and international researchers in the Nature Genetics Journal. Beside Prof. Dr. Schramm the two further C1 project leaders, Prof. Dr. Sven Rahmann and Dr. Sangkyun Lee, also contributed to the publication.
Major concern of doctors is the recurrence of tumors, often leading to worse treatment results. Novel data analysis techniques can focus on differences between primary (at diagnosis) and recurrent neuroblastoma cancer cell genetic profiles. Found genetic patterns provide a chance for upcoming, target-specific therapies.